Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib frontline therapy.
Phase of Trial: Phase IV
Latest Information Update: 18 Dec 2015
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 18 Dec 2015 New trial record